Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

How do parkinsonian signs return after discontinuation of subthalamic DBS?

Temperli P, Ghika J, Villemure JG, Burkhard PR, Bogousslavsky J, Vingerhoets FJ.

Neurology. 2003 Jan 14;60(1):78-81.

PMID:
12525722
2.

Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.

Katayama Y, Kasai M, Oshima H, Fukaya C, Yamamoto T, Ogawa K, Mizutani T.

J Neurosurg. 2001 Aug;95(2):213-21.

PMID:
11780890
3.

Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.

Plaha P, Ben-Shlomo Y, Patel NK, Gill SS.

Brain. 2006 Jul;129(Pt 7):1732-47. Epub 2006 May 23.

4.

Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease.

Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A.

Neurology. 1999 Jul 13;53(1):85-90.

PMID:
10408541
5.

Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.

Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP.

Arch Neurol. 2005 Apr;62(4):554-60.

PMID:
15824252
6.

Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.

Kim HJ, Paek SH, Kim JY, Lee JY, Lim YH, Kim DG, Jeon BS.

Mov Disord. 2009 Feb 15;24(3):329-35. doi: 10.1002/mds.22211.

PMID:
19006187
7.

Lack of motor symptoms progression in Parkinson's disease patients with long-term bilateral subthalamic deep brain stimulation.

Tagliati M, Martin C, Alterman R.

Int J Neurosci. 2010 Nov;120(11):717-23. doi: 10.3109/00207454.2010.518777.

PMID:
20942586
8.

Bilateral effects of unilateral subthalamic deep brain stimulation on Parkinson's disease at 1 year.

Walker HC, Watts RL, Guthrie S, Wang D, Guthrie BL.

Neurosurgery. 2009 Aug;65(2):302-9; discussion 309-10. doi: 10.1227/01.NEU.0000349764.34211.74.

PMID:
19625909
9.

Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study.

Burchiel KJ, Anderson VC, Favre J, Hammerstad JP.

Neurosurgery. 1999 Dec;45(6):1375-82; discussion 1382-4.

PMID:
10598706
10.

Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.

Yamada K, Goto S, Hamasaki T, Kuratsu JI.

Acta Neurochir (Wien). 2008 Jan;150(1):15-22; discussion 22. doi: 10.1007/s00701-007-1451-3. Epub 2008 Jan 10.

PMID:
18180867
11.

Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.

Spottke EA, Volkmann J, Lorenz D, Krack P, Smala AM, Sturm V, Gerstner A, Berger K, Hellwig D, Deuschl G, Freund HJ, Oertel WH, Dodel RC.

J Neurol. 2002 Jun;249(6):759-66.

PMID:
12111311
12.

Effect of short and long term STN stimulation periods on parkinsonian signs.

Sturman MM, Vaillancourt DE, Shapiro MB, Metman LV, Bakay RA, Corcos DM.

Mov Disord. 2008 Apr 30;23(6):866-74. doi: 10.1002/mds.21979.

PMID:
18311827
13.

Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease.

Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE.

J Neurosurg. 2003 Sep;99(3):489-95.

PMID:
12959435
14.

Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.

Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, Pierantozzi M, Brusa L, Scarnati E, Mazzone P.

Brain. 2007 Jun;130(Pt 6):1596-607. Epub 2007 Jan 24.

15.

Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.

Yoshida F, Miyagi Y, Kishimoto J, Morioka T, Murakami N, Hashiguchi K, Samura K, Sakae N, Yamasaki R, Kawaguchi M, Sasaki T.

Stereotact Funct Neurosurg. 2009;87(1):45-9. doi: 10.1159/000195719. Epub 2009 Jan 28.

PMID:
19174620
16.

MRI directed bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease.

Patel NK, Plaha P, O'Sullivan K, McCarter R, Heywood P, Gill SS.

J Neurol Neurosurg Psychiatry. 2003 Dec;74(12):1631-7.

17.

Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.

Sturman MM, Vaillancourt DE, Metman LV, Bakay RA, Corcos DM.

Brain. 2004 Sep;127(Pt 9):2131-43. Epub 2004 Jul 7.

18.

Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation.

Bejjani BP, Gervais D, Arnulf I, Papadopoulos S, Demeret S, Bonnet AM, Cornu P, Damier P, Agid Y.

J Neurol Neurosurg Psychiatry. 2000 May;68(5):595-600.

19.

Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.

Tsai ST, Lin SH, Chou YC, Pan YH, Hung HY, Li CW, Lin SZ, Chen SY.

Stereotact Funct Neurosurg. 2009;87(4):241-8. doi: 10.1159/000225977. Epub 2009 Jun 26.

PMID:
19556833
20.

Chronic inhibition of the subthalamic nucleus in Parkinson's disease.

Krause M, Fogel W, Mayer P, Kloss M, Tronnier V.

J Neurol Sci. 2004 Apr 15;219(1-2):119-24.

PMID:
15050447
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk